ARGX logo
NASDAQ · ARGXBiotechnologyUpdated Nov 5, 2026

argenx SE ROE

Profitability, historical returns, and peer comparisons.

The ROE as of November 2026 (TTM) for argenx SE (ARGX) is 16.86%

According to argenx SE’s latest financial reports and current stock price. The company's current ROE is 16.86%. This represents a change of 160.99% compared to the average of 6.46% of the last 4 quarters.

argenx SE (ARGX) Historical ROE (quarterly & annually)

How has ARGX ROE performed in the past?

The mean historical ROE of argenx SE over the last ten years is -12.10%. The current 16.86% ROE has changed -239.41% with respect to the historical average. Over the past ten years (40 quarters), ARGX's ROE was at its highest in in the December 2024 quarter at 15.74%. The ROE was at its lowest in in the December 2016 quarter at -20.04%.

Quarterly (TTM)
Annual

Average

-12.10%

Median

-13.86%

Minimum

-36.35%

Maximum

18.36%

argenx SE (ARGX) ROE by Quarter and Year

Discovering the peaks and valleys of argenx SE ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 136.76%

Maximum Annual ROE = 18.36%

Minimum Annual Increase = -310.41%

Minimum Annual ROE = -36.35%

Quarterly (TTM)
Annual
YearROEChange
202518.36%21.18%
202415.15%-310.41%
2023-7.20%-71.45%
2022-25.22%56.54%
2021-16.11%-55.68%
2020-36.35%136.76%
2019-15.35%24.02%
2018-12.38%52.07%
2017-8.14%-75.87%
2016-33.73%-17.89%

argenx SE (ARGX) Average ROE

How has ARGX ROE performed in the past?

The current ROE of argenx SE (ARGX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

8.77%

5-year avg

-3.00%

10-year avg

-12.10%

argenx SE (ARGX) ROE vs. Peers

How is ARGX’s ROE compared to its peers?

argenx SE’s ROE is less than UCB S.A. (19.48%), less than Genmab A/S (13.58%), less than Incyte Corporation (7.11%), less than RemeGen Co. Ltd. Class A (105.60%), less than Celltrion, Inc. (7.62%), less than Biogen Inc. (1.86%), less than TG Therapeutics, Inc. (72.30%), less than Alteogen Inc. (41.17%), less than Amgen Inc. (85.59%), less than Ipsen S.A. (11.33%),

Build a custom stock screener for argenx SE (ARGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like argenx SE using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

argenx SE (ARGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like argenx SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is argenx SE's ROE?

How is the ROE calculated for argenx SE (ARGX)?

What is the highest ROE for argenx SE (ARGX)?

What is the 3-year average ROE for argenx SE (ARGX)?

What is the 5-year average ROE for argenx SE (ARGX)?

How does the current ROE for argenx SE (ARGX) compare to its historical average?